Cas:409061-22-9 1-Piperidinecarboxylicacid,2-ethyl-,1,1-dimethylethylester(9CI) manufacturer & supplier

Chemical Name:1-Piperidinecarboxylicacid,2-ethyl-,1,1-dimethylethylester(9CI)

CAS.NO:409061-22-9

Synonyms:N-Boc-2-ethylpiperidine;O-Aethyl-2-oximinopropionsaeure

Molecular Formula:C₁₂H₂₃NO₂

Molecular Weight:213.31700

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.54000

Exact Mass:213.17300

LogP:3.12390

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-Boc-2-ethylpiperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,O-Aethyl-2-oximinopropionsaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,O-Aethyl-2-oximinopropionsaeure Use and application,N-Boc-2-ethylpiperidine technical grade,usp/ep/jp grade.

Related News: As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made due to the continued drop in demand for travel to China and the US Department of State��s decision to raise its China travel advisory to a Level 4. 1-Piperidinecarboxylicacid,2-ethyl-,1,1-dimethylethylester(9CI) manufacturer ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. 1-Piperidinecarboxylicacid,2-ethyl-,1,1-dimethylethylester(9CI) supplier The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). 1-Piperidinecarboxylicacid,2-ethyl-,1,1-dimethylethylester(9CI) vendor Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� 1-Piperidinecarboxylicacid,2-ethyl-,1,1-dimethylethylester(9CI) factory The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively).